有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1R)-1-(1-adamantyl)ethyl]-2-(1,3,4-thiadiazol-2-ylsulfanyl)acetamide | —— | C16H23N3OS2 |
|
—— | (2S)-N-cyclopropyl-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C9H13N3OS2 |
|
—— | (2S)-N-(furan-2-ylmethyl)-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C11H13N3O2S2 |
|
—— | (2S)-N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C14H16FN3OS2 |
|
—— | (1R,6S,7S,9R)-12-imino-9-(4-methylsulfanylphenyl)-10,11-dioxatricyclo[5.3.2.01,6]dodecane-7,8,8-tricarbonitrile | —— | C20H18N4O2S |
|
—— | (2E,5S)-5-[[4-(difluoromethylsulfanyl)phenyl]methyl]-2-[(E)-furan-2-ylmethylidenehydrazinylidene]-1,3-thiazolidin-4-one | —— | C16H13F2N3O2S2 |
|
—— | N-[(1R)-1-(2-chlorophenyl)ethyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H14ClN3OS2 |
|
—— | N-[(1R,2R,3S)-2,3-dimethylcyclohexyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H21N3OS2 |
|
—— | N-[(1S)-1-(3-chlorophenyl)ethyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H14ClN3OS2 |
|
—— | N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-1-(2-methylsulfanylpyrimidin-4-yl)piperidin-4-amine | —— | C14H20N4O2S2 |
|
—— | N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-1-(2-methylsulfanylpyrimidin-4-yl)piperidin-4-amine | —— | C14H20N4O2S2 |
|
—— | N-(1-adamantylmethyl)-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C16H23N3OS2 |
|
—— | 2-(1,3,4-thiadiazol-2-ylsulfanyl)-N-[(1S)-1-thiophen-2-ylethyl]acetamide | —— | C10H11N3OS3 |
|
—— | N-(4-methylcyclohexyl)-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C12H19N3OS2 |
|
—— | (3S)-3-[[[6-amino-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-yl]amino]methyl]piperidin-3-ol | —— | C18H25N5OS |
|
—— | (2S)-N-benzyl-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C13H15N3OS2 |
|
—— | N-[(1S,2R,3S)-2,3-dimethylcyclohexyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H21N3OS2 |
|
—— | (3R)-3-[[[6-amino-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-yl]amino]methyl]piperidin-3-ol | —— | C18H25N5OS |
|
—— | tert-butyl N-[(1S)-1-(5-ethylsulfanyl-1,3,4-oxadiazol-2-yl)-2-methylpropyl]carbamate | 1173667-58-7 | C13H23N3O3S |
|
—— | tert-butyl N-[(1S)-1-[5-[(2-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylpropyl]carbamate | —— | C18H24FN3O3S |
|
—— | 2-[2-[2-(4-Chlorophenyl)sulfanylethoxy]ethylazaniumyl]ethyl-dimethylazanium | —— | C14H25ClN2OS+2 |
|
—— | [(1S)-1-[5-[(3-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-3-methylbutyl]azanium | —— | C14H19ClN3OS+ |
|
—— | [(S)-1-(5-Benzylsulfanyl-[1,3,4]oxadiazol-2-yl)-3-methyl-butyl]-carbamic acid tert-butyl ester | —— | C19H27N3O3S |
|
—— | VAS3947 | —— | C14H10N6OS |
|
—— | N-[(1S,2S)-2-methylcyclohexyl]-2-phenylsulfanylacetamide | —— | C15H21NOS |
|
—— | N-benzyl-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C19H23NOS |
|
—— | N-[(2-chlorophenyl)methyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C19H22ClNOS |
|
—— | N-(1-cyanocyclohexyl)-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C19H26N2OS |
|
—— | 1-methyl-N-[2-(2,3,5,6-tetramethylphenyl)sulfanylacetyl]pyrrole-2-carboxamide | —— | C18H22N2O2S |
|
—— | 1-(5-Phenyl-3,4-dihydropyrazol-2-yl)-2-(2,3,5,6-tetramethylphenyl)sulfanylethanone | —— | C21H24N2OS |
|
—— | (2R)-2-(2-propan-2-ylimidazol-1-yl)-N-[2-(2H-triazol-4-ylsulfanyl)ethyl]propanamide | —— | C13H20N6OS |
|
—— | 2-butylsulfanyl-4-N-[[(3R)-1-methylpyrrolidin-3-yl]methyl]pyrimidine-4,6-diamine | —— | C14H25N5S |
|
—— | N-[(2R)-1-imidazol-1-yl-3,3-dimethylbutan-2-yl]-1-(2-methylsulfanylpyrimidin-4-yl)piperidin-4-amine | —— | C19H30N6S |
|
—— | N-[(1S)-1-(3-chlorophenyl)ethyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C20H24ClNOS |
|
—— | (2S)-N-benzyl-2-(2,3,5,6-tetramethylphenyl)sulfanylpropanamide | —— | C20H25NOS |
|
—— | N-[(4-fluorophenyl)methyl]-2-(2,3,5,6-tetramethylphenyl)sulfanylacetamide | —— | C19H22FNOS |
|
—— | 1-methyl-N-[2-(2,3,4,5,6-pentafluorophenyl)sulfanylacetyl]pyrrole-2-carboxamide | —— | C14H9F5N2O2S |
|
—— | 1-[2,5-dimethyl-1-[[(2R)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-(2,3,5,6-tetramethylphenyl)sulfanylethanone | —— | C23H31NO2S |
|
—— | (2S)-2-(2-propan-2-ylimidazol-1-yl)-N-[2-(2H-triazol-4-ylsulfanyl)ethyl]propanamide | —— | C13H20N6OS |
|
—— | N-(2-phenylsulfanylphenyl)-2-[4-(trifluoromethyl)phenoxy]acetamide | —— | C21H16F3NO2S |
|
—— | N-cycloheptyl-2-(2,3,4,5,6-pentafluorophenyl)sulfanylacetamide | —— | C15H16F5NOS |
|
—— | (2S)-2-(2,3,4,5,6-pentafluorophenyl)sulfanylpropanamide | —— | C9H6F5NOS |
|
—— | 2-butylsulfanyl-4-N-[[(3S)-1-methylpyrrolidin-3-yl]methyl]pyrimidine-4,6-diamine | —— | C14H25N5S |
|
—— | N-[(2S)-1-imidazol-1-yl-3,3-dimethylbutan-2-yl]-1-(2-methylsulfanylpyrimidin-4-yl)piperidin-4-amine | —— | C19H30N6S |
|
—— | 2-[(2R)-4-(6-amino-2-butylsulfanylpyrimidin-4-yl)morpholin-2-yl]ethanol | —— | C14H24N4O2S |
|
—— | 2-[(2S)-4-(6-amino-2-butylsulfanylpyrimidin-4-yl)morpholin-2-yl]ethanol | —— | C14H24N4O2S |
|
—— | ethyl 2,5-dimethyl-4-[2-(2,3,4,5,6-pentafluorophenyl)sulfanylacetyl]-1H-pyrrole-3-carboxylate | —— | C17H14F5NO3S |
|
—— | 4-N-[[(3S)-1,1-dioxothiolan-3-yl]methyl]-2-[(2-methylphenyl)methylsulfanyl]pyrimidine-4,6-diamine | —— | C17H22N4O2S2 |
|
—— | 4-N-[[(3R)-1,1-dioxothiolan-3-yl]methyl]-2-[(2-methylphenyl)methylsulfanyl]pyrimidine-4,6-diamine | —— | C17H22N4O2S2 |
|
—— | 2-butylsulfanyl-4-N-[[(2R)-1,4-dimethylpiperazin-2-yl]methyl]pyrimidine-4,6-diamine | —— | C15H28N6S |
|